---
name: Biomere
slug: biomere
site: cro
website_domain: biomere.com
summary: Boston-area preclinical CRO specializing in non-GLP PK/PD and early toxicology studies in rodent and large animal models, including primates, with AAALAC accreditation and extensive vivarium capacity. Headquartered in Worcester, United States.
tagline: Preclinical PK/PD and early toxicology expertise with extensive vivarium capacity and multidisciplinary scientific support.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: US
tier2_domain_verified: false
updated_at: 2026-09-21T07:04:14.877Z
services_count: 4
modalities_count: 3
indications_count: 4
locations_count: 2
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Biomere

Preclinical PK/PD and early toxicology expertise with extensive vivarium capacity and multidisciplinary scientific support.

Listed on cro.directory.

## Summary

Boston-area preclinical CRO specializing in non-GLP PK/PD and early toxicology studies in rodent and large animal models, including primates, with AAALAC accreditation and extensive vivarium capacity. Headquartered in Worcester, United States.

## At a glance

- HQ country: US

## Services

- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Specialized & Large-Animal Models

## Modalities

- Small Molecule
- Biologics (Other)
- Gene Therapy

## Indications

- Ophthalmology
- Neurology
- Metabolic
- Oncology

## Locations

- Headquarters, Worcester, MA, United States
- West Coast Facility, Richmond, CA, United States

## Certifications

- AAALAC; Identifier: AAALAC accredited; Source: https://biomere.com/about
- OLAW; Identifier: OLAW Assured; Source: https://biomere.com/about
- DEA; Identifier: DEA Licensed; Source: https://biomere.com/about
- USDA; Identifier: USDA Registered; Source: https://biomere.com/about

## Long description

Biomere is a preclinical contract research organization (CRO) located in Worcester, MA, in the greater Boston area. The company specializes in non-GLP PK/PD and early toxicology studies across small and large animal models, including non-human primates.

## Core Capabilities

- **PK/PD Studies**: Comprehensive pharmacokinetics and pharmacodynamics evaluation to support go/no-go decision-making in preclinical drug development
- **Early Toxicology**: Non-GLP toxicology assessments designed to evaluate dosing, distribution, metabolism, efficacy, and off-target effects
- **Animal Models**: Extensive expertise in rodent and large animal models; disease-specific models including ocular, CNS, metabolic, and oncology applications
- **Endpoint Analysis**: Fully equipped laboratories with multidisciplinary scientific support
- **Gene Therapy PK/PD**: Specialized services for gene therapy candidates
- **Colony Management & Surgical Services**: In-house vivarium resources and surgical capabilities

## Regulatory & Accreditation

Biomere is AAALAC accredited, OLAW Assured, DEA Licensed, and USDA Registered. The organization is part of JOINN Laboratories (acquired in 2019), which extends access to GLP-compliant preclinical services through JOINN's facilities in China (Suzhou, Beijing, Wuzhou, Chongqing, Guangzhou) and a secondary U.S. location in Richmond, CA.

## Approach

The company emphasizes a personal, client-focused approach with dedicated project resourcing, model availability, and expedited study start times. Scientific teams work closely with clients to design budget-optimized study protocols that support informed decision-making during the transition from lead optimization to IND-enabling studies.

## Related companies

- [PharmaLegacy Laboratories](/companies/pharmalegacy) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/biomere/pharmalegacy)
- [Creative Bioarray](/companies/creative-bioarray) (In Vivo PK / PD Studies, Preclinical In Vivo Studies) — [Compare](/compare/biomere/creative-bioarray)
- [GemPharmatech](/companies/gempharmatech) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/biomere/gempharmatech)
- [ChemDiv](/companies/chemdiv) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/biomere/chemdiv)
- [Crown Bioscience](/companies/crownbio) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/biomere/crownbio)
- [Noble Life Sciences](/companies/noblelifesci) (In Vivo PK / PD Studies, In Vivo Efficacy Models) — [Compare](/compare/biomere/noblelifesci)
- [Cyagen Biosciences](/companies/apac-cyagen) (In Vivo Efficacy Models, Preclinical In Vivo Studies) — [Compare](/compare/apac-cyagen/biomere)
- [Accelera Srl](/companies/accelera) (In Vivo Efficacy Models, Preclinical In Vivo Studies) — [Compare](/compare/accelera/biomere)

_Profile last updated: 2026-09-21T07:04:14.877Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.